# A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke

> **NCT06987643** · PHASE2 · RECRUITING · sponsor: **EIP Pharma Inc** · enrollment: 90 (estimated)

## Conditions studied

- Moderate to Severe Acute Ischaemic Stroke
- Ischaemic Stroke

## Interventions

- **DRUG:** Neflamapimod
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06987643
- **Lead sponsor:** EIP Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-28
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987643, "A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06987643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*